Reuters Market Eye - Venus Remedies Ltd shares surge as much as 14.9 percent.
Venus will collaborate with Teva Pharmaceutical Industries Ltd to develop an anti-cancer drug, it said in a statement on Tuesday. (https://bsmedia.business-standard.combit.ly/1tBRHtj)
The company did not provide financial details of the deal.
(Reporting by Dipika Lalwani)